• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help
EMA Approvals
-
HMA Approvals
-

EMA:Drugs approved by European Medicines Agency through centralized Procedure. 

HMA:Drugs approved by EU members through Mutual Recognition Procedure.

For more information check in official website of members:

Drug label information in UK

Public Assessment Reports in UK

Marketed drugs in France

Marketed drugs in Italy

Marketed drugs in Switzerland

Marketed drugs in Sweden

Marketed drugs in Germany

Click here for more information

Brand name Nonproprietary Name Authorization date Marketing authorisation holder
Ritonavir Mylan ritonavir 2017-11-09 Mylan S.A.S
Vfend voriconazole 2002-03-19 Pfizer Europe MA EEIG
Modigraf tacrolimus 2009-05-15 Astellas Pharma Europe B.V.
Advagraf tacrolimus 2007-04-23 Astellas Pharma Europe B.V.
Lynparza olaparib 2014-12-16 AstraZeneca AB
Nerlynx neratinib 2018-08-31 Pierre Fabre Medicament
Xevudy sotrovimab 2021-12-17 GlaxoSmithKline Trading Services Limited
Comirnaty Tozinameran, COVID-19 mRNA Vaccine (nucleoside modified) 2020-12-21 BioNTech Manufacturing GmbH
Padcev enfortumab vedotin 2022-04-13 Astellas Pharma Europe B.V.
Evusheld tixagevimab, cilgavimab 2022-03-25 AstraZeneca AB
Tepmetko tepotinib 2022-02-16 Merck Europe B.V.
Pregabalin Zentiva k.s. pregabalin 2017-02-27 Zentiva k.s.
Fampyra fampridine 2011-07-20 Biogen Netherlands B.V.
Mekinist trametinib 2014-06-30 Novartis Europharm Limited
Cervarix human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed) 2007-09-20 GlaxoSmithKline Biologicals S.A.
Emtricitabine/Tenofovir disoproxil Mylan emtricitabine, tenofovir disoproxil 2016-12-16 Mylan Pharmaceuticals Limited
Arsenic trioxide Accord arsenic trioxide 2019-11-14 Accord Healthcare S.L.U.
Breyanzi lisocabtagene maraleucel 2022-04-04 Bristol-Myers Squibb Pharma EEIG
Reagila cariprazine 2017-07-13 Gedeon Richter
Quviviq daridorexant 2022-04-29 Idorsia Pharmaceuticals Deutschland GmbH